Cubist Pharmaceuticals (CBST)

Add to Watchlists Create an Alert
55.49 -0.54  -0.96%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Cubist Pharmaceuticals Cash from Financing Quarterly:

8.157M for March 31, 2013
View Full Chart

Cubist Pharmaceuticals Cash from Financing Quarterly Chart

    Cubist Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 8.157M
    Dec. 31, 2012 -27.42M
    Sept. 30, 2012 15.08M
    June 30, 2012 -66.87M
    March 31, 2012 2.405M
    Dec. 31, 2011 30.93M
    Sept. 30, 2011 -5.904M
    June 30, 2011 27.15M
    March 31, 2011 10.66M
    Dec. 31, 2010 239.92M
    Sept. 30, 2010 4.461M
    June 30, 2010 -11.28M
    March 31, 2010 19.89M
    Dec. 31, 2009 0.522M
    Sept. 30, 2009 2.699M
    June 30, 2009 0.522M
    March 31, 2009 1.236M
    Dec. 31, 2008 6.949M
    Sept. 30, 2008 4.95M
    June 30, 2008 1.573M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    CBST Cash from Financing Quarterly Benchmarks

    Companies
    Optimer Pharmaceuticals 0.749M
    Celgene Corporation -687.40M
    Athersys 21.31M

    CBST Cash from Financing Quarterly Rankings

    Overall 87th percentile
    916 of 7600
    Sector 85th percentile
    94 of 653 in Healthcare
    Industry 81st percentile
    44 of 238 in Biotechnology

    CBST Cash from Financing Quarterly Range, Past 5 Years

    Minimum -66.87M Jun 2012
    Maximum 239.91M Dec 2010
    Average 13.28M